Human Gene MIR135B (ENST00000362189.3) from GENCODE V44
  Description: Homo sapiens microRNA 135b (MIR135B), microRNA. (from RefSeq NR_029893)
RefSeq Summary (NR_029893): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000362189.3
Gencode Gene: ENSG00000199059.3
Transcript (Including UTRs)
   Position: hg38 chr1:205,448,302-205,448,398 Size: 97 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 09:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:205,448,302-205,448,398)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerGencodeHGNCLynx
MalacardsPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in (null)
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  CS266597 - Sequence 289 from Patent WO2005118806.
DL076759 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004409 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421751 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367622 - JP 2012228254-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW412015 - JP 2014000079-A/289: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674361 - JP 2014217381-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067303 - JP 2014012020-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427727 - JP 2014217384-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428530 - JP 2014217385-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429333 - JP 2014217386-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430136 - JP 2014217387-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769393 - JP 2014223080-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058787 - Sequence 289 from Patent EP2298893.
JA059590 - Sequence 289 from Patent EP2298894.
JA073913 - Sequence 289 from Patent EP2281887.
JA105050 - Sequence 289 from Patent EP2302051.
JA106390 - Sequence 289 from Patent EP2302052.
JA107193 - Sequence 289 from Patent EP2302053.
JA107996 - Sequence 289 from Patent EP2302054.
JA108799 - Sequence 289 from Patent EP2302055.
JA109602 - Sequence 289 from Patent EP2302056.
JA192118 - Sequence 289 from Patent EP2290066.
JA193017 - Sequence 289 from Patent EP2290067.
JA193916 - Sequence 289 from Patent EP2290068.
JA194815 - Sequence 289 from Patent EP2290069.
JA195714 - Sequence 289 from Patent EP2290070.
JA196613 - Sequence 289 from Patent EP2290071.
JA197512 - Sequence 289 from Patent EP2290072.
JA198411 - Sequence 289 from Patent EP2290073.
JA199310 - Sequence 289 from Patent EP2290074.
JA200209 - Sequence 289 from Patent EP2290075.
JA201108 - Sequence 289 from Patent EP2290076.
JA218230 - Sequence 289 from Patent EP2281888.
JA226381 - Sequence 289 from Patent EP2292755.
JA229236 - Sequence 289 from Patent EP2292756.
JA257507 - Sequence 289 from Patent EP2284265.
JA278787 - Sequence 289 from Patent EP2281886.
JA284673 - Sequence 289 from Patent EP2281889.
JA292726 - Sequence 289 from Patent EP2287303.
JA317912 - Sequence 289 from Patent EP2314688.
JA374971 - Sequence 289 from Patent EP2322616.
JC221814 - Sequence 289 from Patent EP2471923.
JC268380 - Sequence 289 from Patent EP2471924.
JC340688 - Sequence 289 from Patent EP2471922.
JC469934 - Sequence 289 from Patent EP2471921.
JC990723 - Sequence 289 from Patent EP2808390.
LF714826 - JP 2016165292-A/289: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856760 - JP 2015142597-A/289: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CS266408 - Sequence 100 from Patent WO2005118806.
DL076570 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004220 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261184 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763686 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525906 - Nucleic acid controling mast cell degranulation.
FW421562 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HH932827 - Sequence 39 from Patent EP2239675.
HV304585 - JP 2009531018-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305083 - JP 2009531019-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV970152 - JP 2012523000-A/39: Method for in vitro Diagnosing a Complex Disease.
HW119292 - JP 2013046612-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367433 - JP 2012228254-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411826 - JP 2014000079-A/100: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505126 - JP 2014502606-A/28: MELANOMA TREATMENTS.
HW589621 - JP 2013121348-A/152: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674172 - JP 2014217381-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW799999 - JP 2014530803-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
HZ043283 - JP 2015510401-A/373: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067114 - JP 2014012020-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081909 - JP 2015514392-A/373: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408279 - JP 2015528002-A/876: CHIRAL CONTROL.
HZ413425 - JP 2014060993-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427538 - JP 2014217384-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428341 - JP 2014217385-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429144 - JP 2014217386-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429947 - JP 2014217387-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501636 - JP 2016025853-A/152: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769204 - JP 2014223080-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058598 - Sequence 100 from Patent EP2298893.
JA059401 - Sequence 100 from Patent EP2298894.
JA073724 - Sequence 100 from Patent EP2281887.
JA104861 - Sequence 100 from Patent EP2302051.
JA106201 - Sequence 100 from Patent EP2302052.
JA107004 - Sequence 100 from Patent EP2302053.
JA107807 - Sequence 100 from Patent EP2302054.
JA108610 - Sequence 100 from Patent EP2302055.
JA109413 - Sequence 100 from Patent EP2302056.
JA191929 - Sequence 100 from Patent EP2290066.
JA192828 - Sequence 100 from Patent EP2290067.
JA193727 - Sequence 100 from Patent EP2290068.
JA194626 - Sequence 100 from Patent EP2290069.
JA195525 - Sequence 100 from Patent EP2290070.
JA196424 - Sequence 100 from Patent EP2290071.
JA197323 - Sequence 100 from Patent EP2290072.
JA198222 - Sequence 100 from Patent EP2290073.
JA199121 - Sequence 100 from Patent EP2290074.
JA200020 - Sequence 100 from Patent EP2290075.
JA200919 - Sequence 100 from Patent EP2290076.
JA218041 - Sequence 100 from Patent EP2281888.
JA226192 - Sequence 100 from Patent EP2292755.
JA229047 - Sequence 100 from Patent EP2292756.
JA257318 - Sequence 100 from Patent EP2284265.
JA278598 - Sequence 100 from Patent EP2281886.
JA284484 - Sequence 100 from Patent EP2281889.
JA292537 - Sequence 100 from Patent EP2287303.
JA317723 - Sequence 100 from Patent EP2314688.
JA374782 - Sequence 100 from Patent EP2322616.
JA526002 - Sequence 152 from Patent EP2369011.
JA526509 - Sequence 152 from Patent EP2369012.
JA527016 - Sequence 152 from Patent EP2369013.
JA535945 - Sequence 152 from Patent EP2371971.
JA787950 - Sequence 152 from Patent EP2479285.
JA788448 - Sequence 152 from Patent EP2479286.
JA810782 - Sequence 152 from Patent EP2468890.
JA811280 - Sequence 152 from Patent EP2468891.
JA811778 - Sequence 152 from Patent EP2468893.
JA812276 - Sequence 152 from Patent EP2468894.
JA812774 - Sequence 152 from Patent EP2468895.
JA813272 - Sequence 152 from Patent EP2468896.
JA813770 - Sequence 152 from Patent EP2468897.
JA814268 - Sequence 152 from Patent EP2468898.
JA814766 - Sequence 152 from Patent EP2468899.
JA817009 - Sequence 152 from Patent EP2468892.
JA825821 - Sequence 152 from Patent EP2471956.
JA826319 - Sequence 152 from Patent EP2471958.
JB024606 - Sequence 152 from Patent EP2505668.
JB025104 - Sequence 152 from Patent EP2505669.
JB079491 - Sequence 152 from Patent EP2487252.
JB079989 - Sequence 152 from Patent EP2487253.
JB080487 - Sequence 152 from Patent EP2487254.
JB080985 - Sequence 152 from Patent EP2487255.
JB081483 - Sequence 152 from Patent EP2487256.
JB081981 - Sequence 152 from Patent EP2487257.
JB082479 - Sequence 152 from Patent EP2487258.
JB082977 - Sequence 152 from Patent EP2487259.
JB083475 - Sequence 152 from Patent EP2487260.
JB083973 - Sequence 152 from Patent EP2487261.
JB084471 - Sequence 152 from Patent EP2487262.
JB084969 - Sequence 152 from Patent EP2487263.
JB087647 - Sequence 152 from Patent EP2502630.
JB147851 - Sequence 152 from Patent EP2484782.
JB148349 - Sequence 152 from Patent EP2484783.
JB153074 - Sequence 152 from Patent EP2514433.
JB153572 - Sequence 152 from Patent EP2514434.
JB622161 - Sequence 152 from Patent EP2586454.
JB622659 - Sequence 152 from Patent EP2586455.
JC001722 - Sequence 152 from Patent EP2591794.
JC221625 - Sequence 100 from Patent EP2471923.
JC268191 - Sequence 100 from Patent EP2471924.
JC340499 - Sequence 100 from Patent EP2471922.
JC469745 - Sequence 100 from Patent EP2471921.
JC990534 - Sequence 100 from Patent EP2808390.
JE972009 - Sequence 60 from Patent WO2015118537.
LF404380 - JP 2015509366-A/373: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714637 - JP 2016165292-A/100: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856571 - JP 2015142597-A/100: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051613 - KR 1020150036642-A/879: CHIRAL CONTROL.
LP765572 - Sequence 1 from Patent EP3276009.
LP883651 - Sequence 60 from Patent EP3208338.
LX145683 - JP 2017506228-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LX245240 - JP 2017095482-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
MA353911 - JP 2018075017-A/373: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MP045551 - Sequence 373 from Patent EP3401394.
MP084221 - Sequence 373 from Patent EP3401393.
JD020576 - Sequence 1600 from Patent EP1572962.
FW364003 - Oligonucleotides for modulating target RNA activity.
HI560925 - Sequence 140 from Patent EP2190992.
HI965447 - Sequence 732 from Patent WO2010139812.
HI966290 - Sequence 610 from Patent WO2010139811.
HI967156 - Sequence 610 from Patent WO2010139810.
HV594026 - JP 2010538653-A/140: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594886 - JP 2010539959-A/267: Micromirs.
HW505495 - JP 2014502606-A/397: MELANOMA TREATMENTS.
HZ074234 - JP 2013535982-A/325: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082848 - JP 2015513906-A/205: Stem Cell Microparticles.
HZ157443 - JP 2015130862-A/267: Micromirs.
HZ186316 - JP 2015146814-A/65: Oligonucleotides for modulating target RNA activity.
HZ436629 - JP 2015529450-A/205: Stem Cell Microparticles.
HZ479790 - JP 2015535430-A/296: TERMINALLY MODIFIED RNA.
HZ789721 - JP 2016504050-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401485 - Sequence 732 from Patent WO2011080318.
JA402463 - Sequence 732 from Patent WO2011080315.
JA403470 - Sequence 732 from Patent WO2011080316.
JA406101 - Sequence 732 from Patent EP2336353.
JA427085 - Sequence 418 from Patent WO2011072177.
JA429627 - Sequence 732 from Patent WO2011095623.
JA660641 - Sequence 95 from Patent WO2011131354.
JA808535 - Sequence 7 from Patent WO2012083969.
JB620410 - Sequence 390 from Patent WO2013063544.
JB624320 - Sequence 140 from Patent EP2610342.
JB835738 - Sequence 28 from Patent WO2013057567.
JC171833 - Sequence 205 from Patent WO2013150303.
JC244610 - Sequence 230 from Patent WO2012020308.
JC512453 - Sequence 2706 from Patent WO2014113089.
JC572644 - Sequence 205 from Patent WO2014125276.
JC582332 - Sequence 205 from Patent WO2014125277.
JE954028 - Sequence 205 from Patent WO2015052526.
JE955781 - Sequence 205 from Patent WO2015052527.
JE972142 - Sequence 193 from Patent WO2015118537.
JE978650 - Sequence 95 from Patent EP2865765.
LF137533 - JP 2016507550-A/205: Method of Producing Microparticles.
LF161888 - JP 2016513950-A/1954: Oligomers with improved off-target profile.
LF162498 - JP 2016513095-A/205: Stem Cell Microparticles and miRNA.
LF953250 - JP 2016534103-A/205: Stem Cell Microparticles and miRNA.
LG005595 - KR 1020150004822-A/205: STEM CELL MICROPARTICLES.
LG053291 - KR 1020150059168-A/205: STEM CELL MICROPARTICLES.
LG240530 - KR 1020160035087-A/205: STEM CELL MICROPARTICLES AND MIRNA.
LP726916 - Sequence 610 from Patent EP2883966.
LP819186 - Sequence 610 from Patent EP3296406.
LP939128 - Sequence 610 from Patent EP3184651.
LQ070041 - Sequence 365 from Patent EP2964234.
LV470615 - JP 2016534036-A/205: Stem Cell Microparticles and miRNA.
LX145816 - JP 2017506228-A/193: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LY404951 - KR 1020160117535-A/256: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233673 - JP 2017184756-A/65: Oligonucleotides for modulating target RNA activity.
MA260190 - JP 2017505623-A/256: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA405728 - WO 2018155427-A/502: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA643542 - JP 2017113010-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731426 - JP 2017140048-A/296: TERMINALLY MODIFIED RNA.
MP014813 - Sequence 16 from Patent WO2019016252.
MS833435 - Sequence 140 from Patent EP3112464.
MS834586 - Sequence 732 from Patent EP3112479.
JD034191 - Sequence 15215 from Patent EP1572962.
FW364002 - Oligonucleotides for modulating target RNA activity.
HI560924 - Sequence 139 from Patent EP2190992.
HI965448 - Sequence 733 from Patent WO2010139812.
HI965902 - Sequence 222 from Patent WO2010139811.
HI966768 - Sequence 222 from Patent WO2010139810.
HV593870 - JP 2010538610-A/83: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594025 - JP 2010538653-A/139: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594885 - JP 2010539959-A/266: Micromirs.
HW289791 - JP 2013520158-A/34: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW505315 - JP 2014502606-A/217: MELANOMA TREATMENTS.
HW669835 - JP 2013537538-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW800001 - JP 2014530803-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
HW913445 - JP 2015504307-A/205: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ043172 - JP 2015510401-A/262: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074233 - JP 2013535982-A/324: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081798 - JP 2015514392-A/262: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082780 - JP 2015513906-A/137: Stem Cell Microparticles.
HZ157442 - JP 2015130862-A/266: Micromirs.
HZ186315 - JP 2015146814-A/64: Oligonucleotides for modulating target RNA activity.
HZ392528 - JP 2015180203-A/34: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ436561 - JP 2015529450-A/137: Stem Cell Microparticles.
HZ479791 - JP 2015535430-A/297: TERMINALLY MODIFIED RNA.
HZ789722 - JP 2016504050-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401486 - Sequence 733 from Patent WO2011080318.
JA402464 - Sequence 733 from Patent WO2011080315.
JA403471 - Sequence 733 from Patent WO2011080316.
JA406102 - Sequence 733 from Patent EP2336353.
JA426795 - Sequence 128 from Patent WO2011072177.
JA429628 - Sequence 733 from Patent WO2011095623.
JA791948 - Sequence 350 from Patent WO2012089772.
JA808551 - Sequence 23 from Patent WO2012083969.
JB022448 - Sequence 290 from Patent WO2013026685.
JB023070 - Sequence 324 from Patent WO2013026684.
JB050095 - Sequence 182 from Patent WO2013020926.
JB175263 - Sequence 295 from Patent WO2012101219.
JB620409 - Sequence 389 from Patent WO2013063544.
JB624319 - Sequence 139 from Patent EP2610342.
JB778826 - Sequence 205 from Patent WO2013078283.
JB835759 - Sequence 49 from Patent WO2013057567.
JC171765 - Sequence 137 from Patent WO2013150303.
JC244609 - Sequence 229 from Patent WO2012020308.
JC270175 - Sequence 566 from Patent WO2012020307.
JC512454 - Sequence 2707 from Patent WO2014113089.
JC572576 - Sequence 137 from Patent WO2014125276.
JC582264 - Sequence 137 from Patent WO2014125277.
JE953960 - Sequence 137 from Patent WO2015052526.
JE955713 - Sequence 137 from Patent WO2015052527.
JE972011 - Sequence 62 from Patent WO2015118537.
LF137465 - JP 2016507550-A/137: Method of Producing Microparticles.
LF161587 - JP 2016513950-A/1653: Oligomers with improved off-target profile.
LF162430 - JP 2016513095-A/137: Stem Cell Microparticles and miRNA.
LF404269 - JP 2015509366-A/262: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636367 - JP 2016519076-A/141: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF857634 - JP 2015130879-A/83: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953182 - JP 2016534103-A/137: Stem Cell Microparticles and miRNA.
LG005527 - KR 1020150004822-A/137: STEM CELL MICROPARTICLES.
LG053223 - KR 1020150059168-A/137: STEM CELL MICROPARTICLES.
LG134524 - KR 1020150131312-A/142: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240462 - KR 1020160035087-A/137: STEM CELL MICROPARTICLES AND MIRNA.
LP726528 - Sequence 222 from Patent EP2883966.
LP818798 - Sequence 222 from Patent EP3296406.
LP883653 - Sequence 62 from Patent EP3208338.
LP917444 - Sequence 40 from Patent WO2017153710.
LP938740 - Sequence 222 from Patent EP3184651.
LQ070042 - Sequence 366 from Patent EP2964234.
LQ420443 - Sequence 19 from Patent WO2016127998.
LQ500669 - Sequence 83 from Patent EP3048177.
LQ844120 - Sequence 40 from Patent WO2018138468.
LQ955752 - Sequence 83 from Patent EP2775001.
LV470547 - JP 2016534036-A/137: Stem Cell Microparticles and miRNA.
LV539181 - JP 2016539127-A/182: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LX145685 - JP 2017506228-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LX245242 - JP 2017095482-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LX270632 - JP 2016056210-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY298583 - KR 1020160079824-A/182: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY404950 - KR 1020160117535-A/255: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233672 - JP 2017184756-A/64: Oligonucleotides for modulating target RNA activity.
MA260189 - JP 2017505623-A/255: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA267278 - JP 2018061445-A/12: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA353800 - JP 2018075017-A/262: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA643543 - JP 2017113010-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730779 - JP 2017125065-A/566: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731427 - JP 2017140048-A/297: TERMINALLY MODIFIED RNA.
MA765546 - JP 2017514519-A/112: Small ncRNAs as biomarkers.
MP045440 - Sequence 262 from Patent EP3401394.
MP070451 - Sequence 48 from Patent WO2018231851.
MP084110 - Sequence 262 from Patent EP3401393.
MS673521 - Sequence 324 from Patent EP3135774.
MS833434 - Sequence 139 from Patent EP3112464.
MS834587 - Sequence 733 from Patent EP3112479.
MS901817 - Sequence 290 from Patent EP3156505.
MS904167 - Sequence 83 from Patent EP3138926.
CS548274 - Sequence 1304 from Patent EP1777301.
DJ003758 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027037 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
FU261422 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763924 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV524350 - Nucleic acid controling mast cell degranulation.
FW312014 - DETECTING NUCLEIC ACIDS.
FZ415738 - JP 2010536372-A/18: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH.
HI548975 - Sequence 38 from Patent EP2187900.
HV304823 - JP 2009531018-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305321 - JP 2009531019-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954045 - JP 2012518421-A/957: METHODS OF DETECTING LUNG CANCER.
HW119530 - JP 2013046612-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589859 - JP 2013121348-A/390: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413663 - JP 2014060993-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501874 - JP 2016025853-A/390: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ883160 - JP 2016065089-A/22: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues.
JA526240 - Sequence 390 from Patent EP2369011.
JA526747 - Sequence 390 from Patent EP2369012.
JA527254 - Sequence 390 from Patent EP2369013.
JA536183 - Sequence 390 from Patent EP2371971.
JA715175 - Sequence 957 from Patent EP2401406.
JA788188 - Sequence 390 from Patent EP2479285.
JA788686 - Sequence 390 from Patent EP2479286.
JA811020 - Sequence 390 from Patent EP2468890.
JA811518 - Sequence 390 from Patent EP2468891.
JA812016 - Sequence 390 from Patent EP2468893.
JA812514 - Sequence 390 from Patent EP2468894.
JA813012 - Sequence 390 from Patent EP2468895.
JA813510 - Sequence 390 from Patent EP2468896.
JA814008 - Sequence 390 from Patent EP2468897.
JA814506 - Sequence 390 from Patent EP2468898.
JA815004 - Sequence 390 from Patent EP2468899.
JA817247 - Sequence 390 from Patent EP2468892.
JA826059 - Sequence 390 from Patent EP2471956.
JA826557 - Sequence 390 from Patent EP2471958.
JB024844 - Sequence 390 from Patent EP2505668.
JB025342 - Sequence 390 from Patent EP2505669.
JB079729 - Sequence 390 from Patent EP2487252.
JB080227 - Sequence 390 from Patent EP2487253.
JB080725 - Sequence 390 from Patent EP2487254.
JB081223 - Sequence 390 from Patent EP2487255.
JB081721 - Sequence 390 from Patent EP2487256.
JB082219 - Sequence 390 from Patent EP2487257.
JB082717 - Sequence 390 from Patent EP2487258.
JB083215 - Sequence 390 from Patent EP2487259.
JB083713 - Sequence 390 from Patent EP2487260.
JB084211 - Sequence 390 from Patent EP2487261.
JB084709 - Sequence 390 from Patent EP2487262.
JB085207 - Sequence 390 from Patent EP2487263.
JB087885 - Sequence 390 from Patent EP2502630.
JB148089 - Sequence 390 from Patent EP2484782.
JB148587 - Sequence 390 from Patent EP2484783.
JB153312 - Sequence 390 from Patent EP2514433.
JB153810 - Sequence 390 from Patent EP2514434.
JB622399 - Sequence 390 from Patent EP2586454.
JB622897 - Sequence 390 from Patent EP2586455.
JC001960 - Sequence 390 from Patent EP2591794.
JC334116 - Sequence 34 from Patent EP2487240.
LQ978379 - Sequence 6 from Patent WO2013040251.
LX058148 - JP 2011516400-A/22: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues.
FZ421162 - JP 2010539978-A/62: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW502476 - JP 2014050389-A/62: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
MA800595 - JP 2018183181-A/1466: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800596 - JP 2018183181-A/1467: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129305 - Sequence 205 from Patent EP3470073.
MP162228 - Sequence 205 from Patent WO2019069093.
MP129237 - Sequence 137 from Patent EP3470073.
MP162160 - Sequence 137 from Patent WO2019069093.
MB018390 - JP 2018504915-A/19: A microRNA-based method for early detection of prostate cancer in urine samples.
MP262556 - Sequence 60 from Patent EP3524679.
MP264009 - Sequence 3 from Patent WO2019086603.
MP262558 - Sequence 62 from Patent EP3524679.
MP280735 - Sequence 155 from Patent WO2019111197.
MP283648 - Sequence 155 from Patent WO2019111198.
MB471143 - JP 2019172696-A/60: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
MB471276 - JP 2019172696-A/193: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
MB453612 - JP 2018509178-A/178: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
MB471145 - JP 2019172696-A/62: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000362189.1, ENST00000362189.2, NR_029893, uc010prh.1, uc010prh.2, uc010prh.3
UCSC ID: ENST00000362189.3
RefSeq Accession: NR_029893

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.